Issued Patents All Time
Showing 51–75 of 109 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9186403 | Compositions including triciribine and trastuzumab and methods of use thereof | Jin Q. Cheng | 2015-11-17 |
| 9174969 | Indoline scaffold SHP-2 inhibitors and cancer treatment method | Jie Wu, Nicholas J. Lawrence | 2015-11-03 |
| 9115162 | Effective treatment of tumors and cancer with triciribine and related compounds | Jin Q. Cheng | 2015-08-25 |
| 9101641 | Compositions including triciribine and taxanes and methods of use thereof | Jin Q. Cheng | 2015-08-11 |
| 9040563 | Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I | Andrew D. Hamilton | 2015-05-26 |
| 8993760 | Rock inhibitors and uses thereof | Andrew D. Hamilton | 2015-03-31 |
| 8987474 | Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs | Jie Wu, Nicholas J. Lawrence, Harshani R. Lawrence | 2015-03-24 |
| 8901086 | Compositions including triciribine and methods of use thereof | Jin Q. Cheng | 2014-12-02 |
| 8865666 | Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof | Jin Q. Cheng | 2014-10-21 |
| 8846653 | Delta-tocotrienol treatment and prevention of pancreatic cancer | Mokenge P. Malafa | 2014-09-30 |
| 8828451 | Akt sensitization of cancer cells | Jin Q. Cheng | 2014-09-09 |
| 8822524 | Substrate-mimetic Akt inhibitor | Jin Q. Cheng, Andrew D. Hamilton, Katherine J. Kayser-Bricker | 2014-09-02 |
| 8691799 | Materials and methods for treatment of cancer and identification of anti-cancer compounds | Richard Jove | 2014-04-08 |
| 8691779 | Compositions including triciribine and taxanes and methods of use thereof | Jin Q. Cheng | 2014-04-08 |
| 8673867 | Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof | Jin Q. Cheng | 2014-03-18 |
| 8673868 | Compositions including triciribine and one or more platinum compounds and methods of use thereof | Jin Q. Cheng | 2014-03-18 |
| 8673910 | Proteasome inhibitors for selectively inducing apoptosis in cancer cells | Harshani R. Lawrence, Yiyu Ge, Wayne Charles Guida | 2014-03-18 |
| 8642278 | Inhibition of cell proliferation | Srikumar Chellappan, Nicholas J. Lawrence | 2014-02-04 |
| 8623906 | Carboxy isatin hydrazones and their esters as Shp2 inhibitors | Jie Wu, Nicholas J. Lawrence, Harshani R. Lawrence | 2014-01-07 |
| 8623834 | Compositions including triciribine and trastuzumab and methods of use thereof | Jin Q. Cheng | 2014-01-07 |
| 8609639 | Stat3 inhibitor having anti-cancer activity and methods | James Turkson, Richard Jove, Andrew D. Hamilton | 2013-12-17 |
| 8466157 | Proteasome inhibitors having chymotrypsin-like activity | Harshani R. Lawrence, Yiyu Ge, Wayne Charles Guida | 2013-06-18 |
| 8455543 | Platinum complexes and methods for inhibiting tumor cell proliferation | Heidi Kay, Jay W. Palmer, Joseph A. Stanko | 2013-06-04 |
| 8435959 | Effective treatment of tumors and cancer with triciribine and related compounds | Jin Q. Cheng | 2013-05-07 |
| 8361970 | Growth factor binding molecules | Andrew D. Hamilton | 2013-01-29 |